Psychometric properties of functional mobility outcome measures in children with arthrogryposis multiplex congenita

Ahlam Zidan1,2, Laurie Snider1, Emmanouil Rampakakis1,3

  • 1Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.

Insights

This study validates mobility measures for children with arthrogryposis multiplex congenita (AMC). The findings establish reliable benchmarks for assessing functional mobility in this population.

Area of Science:

  • Pediatric Rehabilitation
  • Orthopedics
  • Movement Science

Background:

  • Arthrogryposis multiplex congenita (AMC) is a rare neuromuscular condition affecting joint mobility.
  • Accurate assessment of functional mobility is crucial for guiding interventions in children with AMC.
  • Existing mobility measures require validation for construct validity, agreement, and minimal important difference (MID) in the AMC population.

Purpose of the Study:

  • To establish the construct validity, agreement, and MID of commonly used mobility measures in children with AMC.
  • To provide evidence-based benchmarks for clinicians and researchers assessing mobility in AMC.
  • To compare the performance of the Functional Mobility Scale (FMS), Gillette Functional Assessment Questionnaire (FAQ), Functional Independence Measure for Children (WeeFIM), and Patient-Reported Outcomes Measurement Information System (PROMIS).

Main Methods:

  • A cohort of 248 children with AMC (mean age 10 years 10 months) was assessed.
  • Convergent, discriminant, and known-groups validity were evaluated using correlation and ANOVA.
  • Agreement was assessed using Cohen's kappa, and MIDs were estimated using distribution-based methods.

Main Results:

  • All four mobility measures demonstrated robust convergent and discriminant validity.
  • Significant differences in mobility were observed across AMC subtypes, supporting known-groups validity.
  • Weak to good agreement was found, with established MIDs for FMS (1 level), FAQ (2 levels), PROMIS (3.19-4.34), and WeeFIM (14.24).

Conclusions:

  • The validated mobility measures offer reliable tools for assessing functional mobility in children with AMC.
  • Established construct validity, agreement, and MIDs provide essential benchmarks for clinical practice and research.
  • These findings support the use of FMS, FAQ, WeeFIM, and PROMIS for evidence-based mobility assessment in pediatric AMC.
Abstract